Detalhe da pesquisa
1.
Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer.
Immunity
; 55(3): 527-541.e5, 2022 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35231421
2.
Tertiary Lymphoid Structures and B cells: Clinical impact and therapeutic modulation in cancer.
Semin Immunol
; 48: 101406, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33248905
3.
Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial.
Lancet Oncol
; 23(5): 612-624, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35390339
4.
Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.
Immunity
; 39(4): 782-95, 2013 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24138885
5.
Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers.
Immunol Rev
; 271(1): 260-75, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27088920
6.
The clinical role of the TME in solid cancer.
Br J Cancer
; 120(1): 45-53, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30413828
7.
Revisiting immune escape in colorectal cancer in the era of immunotherapy.
Br J Cancer
; 120(8): 815-818, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30862951
8.
Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma.
J Hepatol
; 70(1): 58-65, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30213589
9.
TLS in Tumors: What Lies Within.
Trends Immunol
; 37(1): 1-2, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26706045
10.
How molecularly similar are primary and metastatic tissues in renal cell carcinoma? - Authors' reply.
Lancet Oncol
; 23(7): e317, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35772459
11.
Optimal molecular selection to benefit from nivolumab-ipilimumab in clear-cell renal cell carcinoma.
Lancet Oncol
; 23(7): e318, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35772460
12.
Tertiary lymphoid structures in cancer and beyond.
Trends Immunol
; 35(11): 571-80, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25443495
13.
The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome.
Am J Respir Crit Care Med
; 191(4): 377-90, 2015 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25369536
14.
Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer.
Am J Respir Crit Care Med
; 189(7): 832-44, 2014 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24484236
15.
Shaping of an effective immune microenvironment to and by cancer cells.
Cancer Immunol Immunother
; 63(10): 991-7, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25112529
16.
Overall neutralization of complement factor H by autoantibodies in the acute phase of the autoimmune form of atypical hemolytic uremic syndrome.
J Immunol
; 189(7): 3528-37, 2012 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22922817
17.
Unraveling the complex interplay between anti-tumor immune response and autoimmunity mediated by B cells and autoantibodies in the era of anti-checkpoint monoclonal antibody therapies.
Front Immunol
; 15: 1343020, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38318190
18.
A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens.
Blood
; 118(18): 4853-62, 2011 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21908423
19.
An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas.
Clin Cancer Res
; 29(7): 1279-1291, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36374555
20.
Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response.
Blood
; 116(6): 926-34, 2010 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-20439625